Market Place
Sourcing Support
How Boehringer Ingelheim Is Buttressing Its US Business
10 Oct 2025 //
FIERCE PHARMA
Boehringer Breaks IPF Treatment Drought with New FDA approval
09 Oct 2025 //
FIERCE PHARMA
Boehringer Acquires Oncology Program From Accent Therapeutics
08 Oct 2025 //
PR NEWSWIRE
Boehringer Ingelheim’s Jascayd Receives Approval In US
07 Oct 2025 //
FDA
ERS Data: Nerandomilast Lowers Death Risk in IPF, PPF
30 Sep 2025 //
PHARMAWEB
Novartis, Boehringer Debut DTC Programs With Reduced Drug Prices
29 Sep 2025 //
FIERCE PHARMA
Boehringer Ingelheim Launches DTC Platform For Treatment Access
29 Sep 2025 //
GLOBENEWSWIRE
Numab Achieves Milestone in Collaboration with Boehringer
25 Sep 2025 //
GLOBENEWSWIRE
Palatin Gets €5.5M Milestone In Retinal Deal With Boehringer
22 Sep 2025 //
PR NEWSWIRE
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
Boehringer Ingelheim Debuts Advanced Swine Vaccine in the US
03 Sep 2025 //
BUSINESSWIRE
Boehringer Ingelheim`s Hernexeos Receives China Approval
02 Sep 2025 //
GLOBENEWSWIRE
Boehringer, AnGes Ink Deal for HGF Gene Therapy Manufacturing
25 Aug 2025 //
INDPHARMAPOST
Onco360® Chosen as Specialty Pharmacy Partner for HERNEXEOS®
20 Aug 2025 //
GLOBENEWSWIRE
Boehringer, Palatin to Develop Novel Retinal Disease Treatment
18 Aug 2025 //
GLOBENEWSWIRE
Boehringer Honors Young Researchers at 2025 Symposium
11 Aug 2025 //
PR NEWSWIRE
FDA Approves Boehringer `s Lung Cancer Treatment
11 Aug 2025 //
REUTERS
Boehringer’s Hernexeos Receives Approval in US
08 Aug 2025 //
FDA
Boehringer, Click’s CT-155 Meets Endpoint in Schizophrenia
07 Aug 2025 //
GLOBENEWSWIRE
Boehringer Links with Start-Up Re-Vana in $1B+ Eye Deal
29 Jul 2025 //
BIOSPACE
Boehringer `crossing Fingers` Ahead of 2 Key FDA Approvals
26 Jul 2025 //
FIERCE BIOTECH
Solid Growth & Investments Set Stage for 2 Key Launch in H2 2025
24 Jul 2025 //
GLOBENEWSWIRE
Leo Ponies up €90 Million for Boehringer Ingelheim`s Spevigo
15 Jul 2025 //
BUSINESSWIRE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
Boehringer Ingelheim starts Phase II study of BI 1815368
08 Jul 2025 //
GLOBENEWSWIRE
Oxford BioTherapeutics Advances Third Oncology Drug
03 Jul 2025 //
GLOBENEWSWIRE
Boehringer Launches Single-Dose Poultry Vaccine in India
18 Jun 2025 //
EXPRESSPHARMA
Foundation & Boehringer Launch Lung Cancer Research Project
17 Jun 2025 //
PR NEWSWIRE
EFPIA Urges EU to Streamline Clinical Trials Under Biotech Act
12 Jun 2025 //
RAPS
Echosens & Boehringer Ingelheim Expand Collaboration
10 Jun 2025 //
CONTRACTPHARMA
Boehringer, Eko Partner to Detect Heart Murmurs in Dogs
10 Jun 2025 //
GLOBENEWSWIRE
Boehringer `s Biologics Spevigo Receives Suppl Approval in US
28 May 2025 //
FDA
OSE Immunotherapeutics & Boehringer Ingelheim to Present Clinical
23 May 2025 //
GLOBENEWSWIRE
Boehringer To Show SIRP? Blockade Data In ASCO 2025 Trials
22 May 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim`s Vision for Cancer Care at ASCO 2025
22 May 2025 //
PR NEWSWIRE
BioMed X Institute, Boehringer Call for Research Proposal
22 May 2025 //
CONTRACTPHARMA
Boehringer`s Biologics Cyltezo Receives Suppl Approval in US
20 May 2025 //
FDA
Boehringer`s phase 3 lung data get muted response from analysts
20 May 2025 //
FIERCE BIOTECH
Tempus Collaborates with Boehringer Ingelheim on Cancer Pipeline
14 May 2025 //
BUSINESSWIRE
Boehringer begins Phase II study for Geographic Atrophy
07 May 2025 //
GLOBENEWSWIRE
Life Sciences Leaders Unify at Veeva Commercial Summit
06 May 2025 //
PR NEWSWIRE
Datavant, Boehringer Expand Partnership for Real-World Evidence
05 May 2025 //
BUSINESSWIRE
Oxford, Boehringer Ingelheim, Cumulus Neuroscience launch study
29 Apr 2025 //
GLOBENEWSWIRE
Boehringer`s zongertinib data show durable results in HER2 NSCLC
28 Apr 2025 //
GLOBENEWSWIRE
Survey: 90% of animal owners trust vets but underestimate demands
24 Apr 2025 //
GLOBENEWSWIRE
Boehringer slots synthetic lethal program into oncology pipeline
23 Apr 2025 //
FIERCE BIOTECH
Boehringer Ingelheim announces succession in Chairmen and Board
17 Apr 2025 //
GLOBENEWSWIRE
Boehringer, Cue Bio partner for autoimmune & inflammatory diseases
14 Apr 2025 //
GLOBENEWSWIRE
Boehringer boosts ADC portfolio with NBE Therapeutics R&D center
03 Apr 2025 //
GLOBENEWSWIRE
Amid US uncertainty, Boehringer projects `slight` sales increase
02 Apr 2025 //
FIERCE PHARMA
Boehringer Ingelheim reaches more Patients in 2024, plans launches
02 Apr 2025 //
GLOBENEWSWIRE
Salipro Biotech, Boehringer Ingelheim Partner to Accelerate Pipeline
13 Mar 2025 //
GLOBENEWSWIRE
Cognizant and Boehringer Ingelheim Launch One Medicine Platform
11 Mar 2025 //
CONTRACTPHARMA
Spevigo Data In GPP Patient Outcomes Presented At AAD 2025
07 Mar 2025 //
PR NEWSWIRE
Boehringer wins jury verdict in Zantac retrial in Illinois
26 Feb 2025 //
ENDPTS
CDR-Life Hits Fifth Milestone With Boehringer In Geographic Atrophy
25 Feb 2025 //
BUSINESSWIRE
Boehringer Ingelheim launches new trivalent poultry vaccine
24 Feb 2025 //
GLOBENEWSWIRE
Boehringer, Partner Begin Clinical Trial For Inhaled CF Gene Therapy
20 Feb 2025 //
GLOBENEWSWIRE
OXB’s Lentiviral Tech Supports Boehringer’s Ph 1/2 CF Gene Therapy Trial
20 Feb 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim Welcomes Brian As US Pharma President
20 Feb 2025 //
PR NEWSWIRE
